Epinoma

Healthcare Biotechnology Health Diagnostics Life Science

2 open

San Francisco, CA, USAFounded 20208+ employeesSeed raisedSeedPrivate

Last round: seed · Jun 2021(1 rounds total)

“We engineer proteins that control the operating system of biology. ”

Backed by(5 investors)

SeedToB CapitalAsymmetry VenturesSeaX VenturesY CombinatorDVC

We engineer proteins that control the operating system of biology.

Careers ↗

YC S21

About the Company

Epinoma is pushing the boundaries of scientific excellence and protein engineering to make the world a healthier place to live. Our first customer will be the 50B market of blood test developers as our technology can improve their product performance. Longer term, we will build a second generation of epigenetic medicines that are safer and more effective for patients.

Tech Stack

We utilize a protein platform to read and write biological signals called epigenetics. These structural modifications modulate all genes in the human genome and enable us to detect disease earlier and turn disease off.

Founders

Varun Govil

Background in translational medicine with previous biotech and medtech development experience. Passionate about developing technologies that will change patients' lives.

Zhijian Li

Background in chemistry and biomedical science. In depth experience in developing novel methods for diagnosis and prognosis. Passionate about improving patient outcome with innovative sciences and technologies.